268
Gusarova et al.
123.9 (C-5 in Py), 125.7 (Cp in Ph), 128.2 (Co in Ph), 128.2 (Cm in Ph), 132.5 (C-3 in
pyridine ring), 136.3 (C-4 in pyridine ring), 141.6 (d, 3JCP = 17.3 Hz, Cipso in Ph), 148.7
(C-2 in pyridine ring), 149.8 (C-6 in pyridine ring). 31P NMR (CDCl3): δ 48.56 (s + d
satellites 1JPSe= 572 Hz). 77Se NMR (CDCl3), ppm: −71 (d, 1JPSe = 572 Hz).
Anal. Calcd. for C26H33N2PSSe: C, 60.57; H, 6.45; N, 5.43; P, 6.01; S, 6.22; Se, 15.32.
Found: C, 60.51; C, 6.48; N, 5.54; P, 5.89; S, 6.11; Se, 15.23.
(S)-2-(Pyridin-3-yl)piperidinium bis[2-(2-furyl)ethyl]thioselenophosphinate (5b).
23
Obtained as a colorless viscous oil. Yield: 0.44 g (89%). [α]D = −4.6 (c 2.0, EtOH).
FTIR (cm−1): 3344 (NH), 599 (P-S), 531 (P-Se). 1H NMR (CDCl3): δ 1.85–2.10 (m, 6H,
H-C3-5 in piperidine ring), 2.26–2.32 (m, 4H, CH2P), 2.90–2.97 (m, 4H, CH2Fur), 3.07
(ddd, 1H, 2J = 12.4 Hz, 3JHH = 9.7 Hz, 3JHH = 2.7 Hz, H-C6ax in piperidine ring), 3.71 (d,
1H, 2JHH = 12.4 Hz, HC6eq in piperidine ring), 4.23 (dd, 1H, 3JHH = 9.2 Hz, 3JHH = 13.6
Hz, HC2ax in piperidine ring), 5.94 (d, 2H, 3JHH = 2.4 Hz, H-C4 in furan ring), 6.22 (br.
s, 2H, H-C3 in furane ring), 7.24 (br. s, 2H, H-C5 in furan ring), 7.28-7.31 (m, 1H, H-C5
in pyridine ring), 8.18 (d, 1H, 3JHH = 7.8 Hz, H-C4 in pyridine ring), 8.39 (br. s, 2H, NH),
8.45 (d, 1H, 3JHH = 4.1 Hz, H-C6 in pyridine ring), 8.71 (s, 1H, H-C2 in in pyridine ring).
13C NMR (CDCl3): δ 22.3 (C-4 in piperidine ring), 22.9 (CH2Fur), 23.0 (C-5 in piperidine
ring), 30.7 (C-3 in piperidine ring), 40.0 (d, 1JCP = 44.4 Hz, CH2P), 45.5 (C-6 in piperidine
ring), 58.6 (C-2 in piperidine ring), 104.8 (C-3 in furan ring), 110.0 (C-4 in furan ring),
124.0 (C-5 in furan ring), 133.0 (C-3 in furan ring), 136.2 (C-4 in furan ring), 140.8 (C-5
in furan ring), 148.7 (C-2 in furan ring), 149.8 (C-6 in furan ring), 141.6 (d, 3JCP = 20.6
Hz, C-2 in furan ring). 31P NMR (CDCl3): δ 47.76 (s + d satellites 1JPSe = 576 Hz). 77Se
NMR (CDCl3): δ -78 (d, 1JPSe = 576 Hz).
Anal. Calcd. for C22H29N2O2PSSe: C, 53.33; H, 5.90; N, 5.65; P, 6.25; S, 6.47; Se,
15.94. Found: C, 53.16; H, 5.88; N, 5.49; P, 6.10; S, 6.34; Se, 15.78.
(R)-(6-Methoxyquinolin-4-yl)[(2S,4S,8R)-8-vinylquinuclidin-2-yl]methanol bis(2-
phenethyl)thioselenophosphinate (7a). Obtained as a white powder. Yield: 0.61 g (90%),
mp. 122–125◦C (ether). [α]D = −4.9 (c 2.0, EtOH). FTIR (cm−1): 3427 (OH), 3082,
23
1
3059 and 3024 (NH), 587 (P-S), 528 (P-Se). H NMR (CDCl3): δ 1.22–1.27 (m, 1H, H-
C3ax in quinuclidine ring), 1.76–1.84 (m, 1H, H-C4 in quinuclidine ring), 1.94–2.00 (m,
1H, H-C5ax in quinuclidine ring), 2.07–2.13 (m, 2H, H-C3eq, 5eq in quinuclidine ring),
2.43–2.50 (m, 4H, CH2P), 2.64–2.71 (m, 1H, H-C8 in quinuclidine ring), 3.05–3.11 (m, 4H,
CH2Ph), 3.25–3.31 (m, 1H, H-C7ax in quinuclidine ring), 3.36–3.57 (m, 3H, H-C2,6ax,7eq
in quinuclidine ring), 4.01 (s, 3H, MeO), 4.59–4.66 (m, 1H, H-C6eq in quinuclidine ring),
5.00 (d, 1H, 3JHH = 10.5 Hz, H2C=), 5.05 (d, 1H, 3JHH = 17.0 Hz, H2C=), 5.31 (br s, 2H,
NH, OH), 5.54 (dddd, 1H, 3JHH = 10.5, 17.0 Hz, HC=), 6.81 (s, 1H, CHOH), 7.11–7.24
(m, 10H, Ph), 7.33 (d, 1H, 3JHH = 9.2 Hz, H-C8 in quinoline ring), 7.47 (d, 1H, 3JHH = 2.2
Hz, H-C5 in quinoline ring), 7.67 (d, 1H, 3JHH = 4.5 Hz, H-C3 in quinoline ring), 7.98 (d,
1H, 3JHH = 9.2 Hz, H-C7 in quinoline ring), 8.72 (d, 1H, 3JHH = 4.5 Hz, H-C2 in quinoline
ring). 13C NMR (CDCl3): δ 19.3 (C-3 in quinuclidine ring), 24.6 (C-5 in quinuclidine ring),
26.7 (C-4 in quinuclidine ring), 30.2 (CH2Ph), 37.2 (C-8 in quinuclidine ring), 44.0 (d,
1JCP = 43.3 Hz, CH2P), 45.2 (C-6 in quinuclidine ring), 54.8 (C-7 in quinuclidine ring),
57.2 (MeO), 60.0 (C-2 in quinuclidine ring), 65.9 (CHOH), 100.6 (C-5 in quinoline ring),
117.0 (=CH2), 119.1 (C-7 in quinoline ring), 122.3 (C-3 in quinoline ring), 125.7 (C-9 in
quinoline ring), 125.8 (Cp in Ph), 128.2–128.3 (Co,m in Ph), 131.5 (C-8 in quinoline ring),